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An essential component in the response of T lymphocytes to mitogens and an-
tigens is the expression of genes encoding lymphokines and IL-2-R. This induction
can be monitored by hybridizing complementary DNA or RNA probes to the corre-
sponding mRNA by the northern blotting technique (1). The latter requires large
numbers of cells, and it does not provide direct information on the frequency of
lymphocytes capable ofexpressing these genes or the level of mRNA per active cell.
Such information is ofconcern in primary populations that consist of different lym-
phocyte subsets with distinct functional potentials. In situ hybridization potentially
would allow one to use smaller numbers of cells and to detect induced genes at the
level of individual lymphocytes.
In this paper, the mRNAs for IL-2 and the low-affinity IL-2-R have been detected
by in situ hybridization ofhuman T cellsthat have been stimulatedwith three different
mitogens, PHA, anti-CD3, and anti-CD28, in conjunction with the tumour pro-
moter PMA. For each of the mitogens, IL-2 mRNA is only found in a minority
of the cells (20% or less) and for a short time, between 8 and 16 h after stimulation.
In contrast, IL-2-R mRNA is present for a much longer time and in most cells.
Using this approach I have analyzed the levels of IL-2 and IL-2-R mRNA in the
CD4+ and CD8 + T cell subsets, and have examined the effects of adherent cells
and cyclosporin A (CSA)' on lymphokine gene expression.
Materials and Methods
Materials.
￿
Leukocyte-rich buffy coats were purchased from the NY Blood Center; PHA-
M was from Gibco Laboratories, Grand Island, NY; OKT3 anti-CD3 mAb was from Ortho
Diagnostic Systems Inc., Westwood, MA; PMA from Sigma Chemical Co., St. Louis, MO;
and Ficoll-Hypaque was from Pharmacia Fine Chemicals, Piscataway, NJ. Colleagues kindly
supplied us with CSA (J . F Borel and B. Ryffel, Sandoz Pharmaceutical, Basel, Switzerland)
and the 9.3 anti-CD28 mAb (Dr. J . Laurence, Cornell University Medical Center, NY, and
Dr. A. Moretta, Ludwig Institute for Cancer Research, Lausanne, Switzerland.
Cell Culture.
￿
Bloodmononuclear cells were obtained by applying 10 ml ofhuffy coat prepa-
rations to 10 ml Ficoll-Hypaque. After centrifugation, the interface ofmononuclear cells was
washed and cultured at 106 cells/ml in complete medium consisting of RPM1 1640 (Gibco
Laboratories) supplemented with 5% heat-inactivated FCS (Sterile Systems, Logan, UT),
20 ltg/ml gentamycin sulfate, 5 x 10-5 M 2-ME, and optimal levels of different mitogens:
OKT3 at 30 ng/ml, PHA at 1%, PMA at 5 ng/ml, and 9.3 mAb at a 1:2,500 dilution of
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ascites fluid. To separate CD4 and CD8 subsets, nylonwool-nonadherent T cells were coated
with OKT8 or OKT4 hybridoma culture supernatant, respectively (American Type Culture
Collection, Rockville, MD), washed, and centrifuged onto Petri dishes (model 1005; Falcon
Labware, Oxnard, PA) coated with anti-mouse Ig (Jackson Immunochemicals, Avondale,
PA). The nonadherent cells were examined by FAGS and found to be >99% depleted of the
T cells subset that was reactive with the panning mAb. CD28' cells, which lack the OKMI
or CD11b antigen (2), were enriched by panning nylon wool-nonadherent T cells coated with
OKMI hybridoma supernatant.
Cytocentrifuged Cell Preparations.
￿
Glass slides were coated for 3 h in Denhardt's medium
(0.02% BSA, 0.02% polyvinylpyrrolidone, 0.02% Ficoll Type 400, 3 x SSC) at 65°C, dipped
briefly in H20, transferred to ethanol-acetic acid (3:1 vol/vol) for 20 min, and air dried. 105
cells were cytospun for 3 min at 950 rpm onto the coated glass slides. The slides were air
dried and immediately fixed in freshly prepared 4% paraformaldehyde in PBS without Cal'
and Mgt' (PD) for 20 min at room temperature. The slides were rinsed for 3 min in 3 x
PD, and twice for 1 min in 1 x PD, and dehydrated for 5 min in graded ethanol solutions
(50%, 70%, 95%, 100%). After air drying, the slides were stored at -20°C with dessicant.
Preparation ofRNAProbes.
￿
The PST-1-PST-1 fragment from the c-DNA IL-2 clone pFCGF5
(3) and the Sau-3A-Sau-3A fragment from the human IL-2-R clone (4) were subcloned into
pIBI-30 vector (Int. Biotech. Inc., New Haven, CT). The recombinant plasmids were linear-
ized with the appropriate restriction enzyme. Radioactive sense and antisense RNA probes
were generated using T3 or T7 polymerase and 35S-UTP (NEN; DuPont Co., Wilmington,
DE). DNA templates were digested with DNAse I (1 U/gg DNA; Promega Biotec, Madison,
WI). The RNA probes were ethanol precipitated after adding 10 ug yeast tRNA. About 2 x
108 cpm/pg DNA was obtained.
In Situ Hybridization.
￿
The fixedcells on slides were rehydrated, treated for 20 min at room
temperature with 0.2 N HCl, washed in 1 x PD, and immersed in 2 x SSC for 15 min at
70°C. The slides were fixed for 5 min in freshly prepared 4% paraformaldehyde at room
temperature, and washed in 3 x PD for 5 min and 1 x PD for 1 min. The slides were acetylated
for 10 min in 0.1 M triethanolamine and 0.25% acetic anhydride, washed for 5 min in 2x
SSC, dehydrated, and allowed to dry. 20 tit ofhybridization mixture was loaded on each slide.
This contained 10 wl formamide, 2 p120 x SSC, 100 mM DTT, 2 ul of 10 mg/ml shared salmon
sperm DNA, 2 wl of 10 mg/ml tRNA, 0.8 Wl of nuclease-free BSA at 50 mg/ml, 0.2 ul of
ribonucleotide-vanydyl complex (BioLabs, Beverly, MA) and 106 cpm of 35S-labeled probe.
Siliconized coverslips were placed on top of the cells and sealed with rubber cement. The
slides were incubated at 50°C overnight and then washed by incubating as follows: twice in
50% formamide in 2x SSC for 30 min at 55°C, twice in 2 x SSC for 30 min at 55°C with
gentle shaking, once at 37°C for 30 min in 2x SSC containing 10 Rg/ml RNAse (Sigma
Chemical Co.) and 10 U/ml RNAse Ti (Boehringer Mannheim Biochemicals, Indianapolis,
IN), twice in 50% formamide in 2x SSC for 30 min at 55°C, and twice in 2x SSC for 30
min at 55°C. Dehydrated slides were dipped in NTB2 emulsion (Eastman Kodak, Rochester,
NY) diluted 1 :1 with 0.6 M ammonium acetate. After 1-4 wk, the slides were developed in
Kodak D19 for 5 min, rinsed for 1 min in tap water, and fixed for 5 min in Kodak fixer A.
The slides were washed with tap water for 30 min and stained with Giemsa. Each data point
represents the evaluation of four slides. Cells were considered positive for gene expression
when there were at least five times as many grains as the cells with the highest background.
Slides that were hybridized with labeled sense probes gave background labeling.
Results
Detection of IL-2 and IL-2-R mRNA by In Situ Hybridization.
￿
Blood mononuclear
cellswere stimulated with the combination of lectin, PHA, and the tumorpromoter,
PMA. The cells were examined by in situ hybridization using the optimal time points
for IL-2 and IL-2-R mRNA expression as described previously with northern anal-
ysis (1). When an IL-2 probe synthesized in the antisense orientation (complemen-
tary to cellular mRNA) was used, a fraction of the cells hybridized strongly. WhenGRANELLI-PIPERNO
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the senseRNA probewas tested, only background labeling wasnoted (Fig. 1) . Specific
labeling with the antisenseprobe also wasobtainedwhen cellswere probed forIL-2-
R mRNA (Fig . 1) .
Frequency of Cells Expressing IL-2 and IL-2-R mRNA : Kinetics and Comparison ofDifferent
Mitogens and T Cell Subsets. The kinetics of IL-2 mRNA induction, after stimula-
tion ofblood leukocytes with mitogens, was studied in CD4- (CD8+ , cytolytic) and
CD8' (CD4+, helper)T cell subsets . For either OKT3/PMA or PHA/PMA stim-
ulation, cells expressing IL-2 mRNA could be detected within 4 h (Fig. 2,A and
B) . By 8-16 h of culture, there was a significant increase both in the number of la-
beled cells (Fig . 2) and the amount ofIL-2mRNA expressed by each cell, as judged
by the number of grains counted per cell (not shown) . The number of cells with
IL-2 mRNA then decreased at later times . By 36 h of culture, no cells expressing
IL-2 mRNA could be detected .
The expression of IL-2-R mRNA showed different kinetics from IL-2 . NomRNA
was detectable at 4 h. The signal then increased progressively with time reaching
a maximum at 36 h where 30-50% of the cells were labeled (Fig . 2, C and D) .
Both T cell subsets synthesized IL-2 mRNA when stimulated with either of 3
mitogens ; PHA, anti-CD3, or anti-CD28 (Fig . 3) . However, theCD8+ subset con-
tained a lower frequency of cells with IL-2 mRNA, and the number of grains per
cell was lower (Figs . 3 and 4) .
Expression of IL-2 Transcripts in OKT3-stimulated T Cells : Effects ofPMA and Adherent
Cells . I next compared T cell proliferation, IL-2 production, and the frequency
of CD4+ or CD8+ cells with IL-2 mRNA after stimulation with anti-CD3 mAb
anddifferent accessory signals . T cells stimulated with anti-CD3 and adherent cells
proliferated to a similar extent to T cells stimulated with anti-CD3 plus PMA, or
anti-CD3 plusPMA and adherent cells . However, the accumulation of IL-2 in the
culture medium increased markedly withPMA (Table I) . By in situ hybridization,
a small but significant number ofCD4* andCD8+ cells were identified as positive
FIGURE 1 .
￿
Detectionby in situ
hybridization ofIL-2 and IL-2-
R mRNA in mitogen-stimu-
lated blood mononuclear cells .
The cells were stimulated with
PHA/PMA, and then hybrid-
izedwith an antisense probe for
IL-2 (upper left) or IL-2-R
mRNA (upper right) or with a
sense probe for IL-2 (bottom left)
or IL-2-RmRNA (bottom right) .
Stimulation was 10 h for IL-2
and 24 h for IL-2-R. Shown
here are three cells that were la-
beled heavily with the antisense
IL-2 probe, and many more
were labeled with the IL-2-R
probe.165 2
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FIGURE 2 .
￿
Kinetics of appearance of
IL-2 andIL-2-R mRNA-bearing cells
after stimulation with mitogens. Nylon
wool-nonadherent CD4* (CD8- ) or
CD8* (CD4- ) T cells were purified
bypanning with anti-CD8 oranti-CD4
p
￿
mAb, andthen the lymphocytes were
stimulated withOKT3 (30 ng/ml) and
PMA (5 ng/ml), or PHA (1%) and
PMA. At the indicated times, the cells
were analyzed for IL-2-R and IL-2
mRNA by in situ hybridization .
for IL-2 transcripts after stimulation withOKT3 mAb in the absence ofPMA . How-
ever, PMA increased the frequency of cells expressing IL-2 mRNA dramatically
as well as the number of copies of IL-2 mRNA cell (Table I) . Therefore, it seems
that IL-2mRNAand IL-2 protein (activity) can be superinduced beyond that needed
for lymphocyte DNA synthesis in culture.
CSA Blocks IL-2 but not IL-2-R Transcripts .
￿
The effect of CSA on the induction
of IL-2 and IL-2-R mRNA by a number of stimuli was also analyzed by in situ
hybridization . Confirming previous results obtained by northern blot (1, 5-7), 0 .3-1
gg/ml CSA decreased the level of IL-2 transcripts when T cells were stimulated with
PHA/PMA (Fig . 5) or anti-CD3 plus PMA (not shown) . However higher concen-
trations ofCSA (3 gg/ml) were necessary to obtain a 50-70'7o inhibition when the
stimulus was anti-CD28 plusPMA (Fig. 6) . Without CSA, 19% ofthe cells expressed
IL-2 mRNA vs . 4-8% in its presence . It is noteworthy that the number of grains
on the positive cells was reduced by CSA . The findings were confirmed by meas-
uring IL-2 production . Synthesis of IL-2 was totally blocked on T cells stimulated
with OKT3/PMA or PHA/PMA . However, the CD28 pathway was more resistant
FIGURE 3 .
￿
IL-2mRNA accumulation
in CD4* and CD8* cells stimulated
with different mitogens . The cells were
induced for 12 h with the indicated
mitogens, and the number of grains
were counted on positive cells .GRANELLI-PIPERNO
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FIGURE 4 . A comparison of
IL-2 mRNA levels in CD4*
(CD8- ) and CD8* (CD4- ) T
cells . The lymphocyte subsets
were prepared by panningwith
anti-CD8 and anti-CD4 mAb
and then were stimulated for 12
h with PHA andPMA before
analysis byin situ hybridization .
to CSA; 70% inhibition was obtained by exposing the cells to CSA for 30-60 min
before stimulation (Table II) .
In contrast to the effects on IL-2 mRNA, CSA did not reduce the level of IL-2-R
mRNA (Fig . 5) . Equal numbers of cells expressed IL-2-R mRNA in the presence
andabsenceofCSA, and thedistribution of grains at the single cell levelwassimilar.
Discussion
The technique of in situ hybridization can be applied to visualize IL-2 and IL-2-
R gene expression in activated T cells, even though these genes are expressed at
relatively low levels . The approach offers an advantage over northern blot hybridiza-
tion sinceonecan obtain, on relatively small samples, information on the frequency
of cells expressing a specificmRNA, as well as the amount ofmRNA/cell . Northern
blotting has been previously demonstrated that IL-2 is an inducible gene with a
shortmRNA half life (1). Less clear are the proportion of stimulated cells capable
of expressing IL-2, the amount of IL-2 produced per cell, and the ability ofdifferent
subpopulations ofT cells to produceIL-2 . Theexpression ofthe low-affinity IL-2-R
at the single cell level can be analyzed with mAb such as antiTAC (8), but to date
only one study has reported visualization of IL-2 at the single cell level using anti-
bodies (9).
The results with in situ hybridization show that a discrete number of activated
T cells express IL-2 mRNA . Since the cells are not synchronized, and since IL-2
mRNA is rapidly turned on and off, the analysis represents the relative frequency
of cells that at a given time express IL-2 transcript . IL-2 mRNA can be detected
after 4 h of stimulation, and it peaks forjust a short time between 8 and 16 h . Both
subsets of T cells express IL-2 mRNA after stimulation with either PHA/PMA,
a-CD3/PMA, or a-CD28/PMA . Yet the helper subset (CD8- ) contained 2-3-fold
more positive cells and more RNA (higher grain counts) per cell .
The data comparingDNA synthesis with the levels ofIL-2 activity andIL-2mRNA
(Table I) raise interesting questions with respect to the amount ofIL-2 one requires
for optimal lymphocyte growth . It seems that under more physiologic conditions,
such as theMLR (unpublished observations) and the use of accessory cellswithout
PMA (Table I), one observes very low numbers of cells (0 .5-3%) with IL-2 mRNA1654
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FIGURE 5 .
￿
CSAreduces the levels ofIL-2, but not IL-2-R, transcripts . Blood mononuclear cells
were cultured with PHA/PMA in the presence (bottom panels) or absence (top panels) of CSA (1
pg/ml). At 8 h for IL-2, and 24 h for IL-2-R, the cells were analyzed for transcripts by in situ
hybridization .
by in situ hybridization but high levels ofDNA synthesis . Either a very low number
of cells needs to make lymphokine for much larger numbers of cells with IL-2-R
to respond, or many cells are making small amounts of IL-2 as an autocrine factor
and the level of IL-2 mRNA is too low to detect by the in situ method . The use
of accessory stimuli like PMA may lead to superinduction of IL-2 mRNA .
The expression of IL-2-R mRNA showed considerable differences compared with
the expression of IL-2 mRNA. IL-2-R transcripts were present in 30-50% of cells
after stimulation by only one stimulus like OKT3 or two stimuli, i.e ., OKT3/PMA
none 0 .3 1
CSA [leg/mll
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FIGURE 6 .
￿
Effect of CSA IL-2 mRNA
production on stimulated T cells. T cells
were cultured for 8hwith 9.3 (anti-CD28)
plusPMAorPHAplusPMAin the pres-
ence or absence ofdifferent concentrations
of CSA. Cells were analyzed for IL-2
mRNA by in situ hybridization.1656
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TABLE II
IL-2 Production by Stimulated T Cells: Effect of CSA
T cells prepared as described in Materials and Methods were preincubated for
30 min with the indicated doses of CSA. Cells (106/ml) were stimulated with
anti-CD28 (1 :2,500 dilution ofascitic fluid), PHA (1 %), or anti-CD3 (30 ng/m)
plus PMA (5 ng/ml). After 18 h, supernatants were collected and assayed for
IL-2 production using CTLL-2 cells .
or PHA/PMA. Kinetic analysis showed that maximum expression of IL-2-R was
achieved after 20-40 h ofstimulation in contrast to IL-2, where the peak ofexpres-
sion was between 8 and 16 h. This suggests that the expression of IL-2 precedes
expression ofIL-2-R. At the present time we do not have information on the sta-
bility ofthesetwo mRNAs. Yetthe results suggest that small numbers ofcellsmaking
IL-2 could influence much larger numbers of cells with IL-2-R.
CSA blocks IL-2 at thelevel ofnucleartranscription (1, 5), soit wasnot surprising
to obtain similar resultswhen cells stimulated withOKT3/PMA orPHA/PMA were
analyzedby in situhybridization. WithCSA, the percentage ofcells expressing IL-2
was dramatically reduced (from 20% to 0.1-1%), and the level ofmRNA in the few
positive cellsdecreased significantly asjudged by grain counts. However, after stim-
ulation with anti-CD28 and PMA, both IL-2 production and IL-2 transcripts were
partially inhibited. This inhibition was achieved by incubating the cells for 1 h be-
fore stimulation with 3 jig/ml CSA. Taken together, the data demonstrate that the
CD28 pathways, although more resistant to the drug, are not completely resistant
to CSA. These experiments were stimulated by the finding ofJune et al. (10), who
recently reported that expression ofIL-2 was CSA insensitive usinganti-CD28 and
PMA, but CSA sensitive using CD3 and CD28. In their work, CSA was used at
0.5-1.5 wg/ml without a preincubation period. A physiologic ligand for CD28 has
yet tobe identified, so it isunclear whetherthe relativeresistance ofthe CD28 pathway
to CSA would be manifest as resistance to the drug in patients who are being im-
munosuppressed. CD28 antigen has been recently cloned (11), thus facilitating the
study of its function.
In situhybridization confirmed priorobservations (1) onthe insensitivityofIL-2-
R mRNA expression to CSA. The frequency of cells with IL-2-R transcript was
not changed by this drug, and the number of grains counted on positive cells was
not altered as well.
In situ hybridization could become an important tool for monitoringlymphocyte
activation in vitro and invivo. Aconcern about studies oflymphokine gene expres-
sion in vivo is that the technique may not be sensitive enough to detect biologically
relevant levels of IL-2, either because the level ofmRNA per cell is too low, or be-
causevery fewIL-2-producing cells arerequired to mediated Tcell responses (Table I).
Stimuli None
IL-2 production with
0.3
CSA (gg/ml)
1 3
U/ml
CD28/PMA 53 35 18 10
OKT3/PMA 50 3 <1 <1
PHA/PMA 72 4 1 <1Summary
RNA-RNA in situ hybridization was used to study the frequency of cells producing
mRNA for IL-2 and IL-2-R in T lymphocytes stimulated by either ofthree mitogens:
anti-CD3, anti-CD28, or PHA. Both CD4+ and CD8+ T cells expressed transcripts
for IL-2 and the low-affinity IL-2-R when stimulated with these mitogens plus PMA.
IL-2 transcripts peaked at 8-16 h, and IL-2-R at 24-40 h. Cyclosporin A (CSA)
inhibited the synthesis of IL-2, but not IL-2-R mRNA, after stimulation by PHA
or anti-CD3 . However, higher concentrations of CSA were necessary to achieve
50-70% inhibition after stimulation with anti-CD28. At optimal points 12-22%
of CD4+ and 5-13% of CD8+ cells expressed IL-2 mRNA, while 30-50% of cells
of both subsets had IL-2-R mRNA. The IL-2 grain counts, which relate to the level
of mRNA/cell, were higher in the CD4+ subset but could be increased several fold
in the CD8+ subset in the presence of adherent accessory cells. The use of PMA
as an accessory stimulus, in addition to adherent cells, greatly increased the fre-
quency of lymphocytes with IL-2 mRNA and the amount of IL-2 activity in the
culture medium, but the proliferative response was not significantly boosted. These
observations indicate at the single cell level that many CD4+ or CD8+ lymphocytes
can make IL-2 mRNA, and that the induction of IL-2 with several stimuli is re-
duced by CSA and enhanced by PMA.
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